Search Within

Oscar Boutros Lahoud

Formats
  1. Meeting Abstract (87)
  2. Journal Article (37)
  3. Research Letter (6)
  4. Correspondence (2)
  5. Review (1)
Groups
  1. Department of Medicine (133)
  2. Hematologic Malignancies, Division of (133)
  3. Center for Hematologic Malignancies (129)
  4. Survivorship Research (125)
  5. Bone Marrow Transplant (123)
  6. CTCR Scholars (112)

More Groups

People
  1. Sergio Giralt (107)
  2. Gunjan Shah (105)
  3. Heather Landau (103)
  4. Michael Scordo (98)
  5. David Chung (93)
  6. Hani Hassoun (89)

More People

Years
  1. 2025 (2)
  2. 2024 (11)
  3. 2023 (42)
  4. 2022 (28)
  5. 2021 (10)
  6. 2020 (18)

More Years

Publications
  1. Blood (46)
  2. Clinical Lymphoma, Myeloma and Leukemia (26)
  3. Biology of Blood and Marrow Transplantation (10)
  4. Blood Advances (9)
  5. Journal of Clinical Oncology (8)
  6. Leukemia and Lymphoma (6)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Elsevier Inc. (41)
  3. American Society of Clinical Oncology (8)
  4. Nature Publishing Group (7)
  5. Taylor & Francis Group (6)
  6. John Wiley & Sons (3)

More Publishers

Results (133)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Gilbert, L. J.; Hanley, D. M.; Flynn, J. R.; Devlin, S. M.; Nguyen, L. K.; Ruiz, J. D.; Shah, G. L.; Sauter, C. S.; Chung, D. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: A prospective observational cohort study
    Journal Article

    Korde, N.; Tavitian, E.; Mastey, D.; Lengfellner, J.; Hevroni, G.; Zarski, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; more...
    eClinicalMedicine (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach
    Journal Article

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Flynn, J.; Salvatore, S. P.; Jaffer-Sathick, I.; Rossi, A. C.; Lahoud, O.; Hultcrantz, M.; Shah, U. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): Interim analysis of a randomised, open-label, phase 3 trial
    Journal Article

    Dytfeld, D.; Wróbel, T.; Jamroziak, K.; Kubicki, T.; Robak, P.; Walter-Croneck, A.; Czyż, J.; Tyczyńska, A.; Druzd-Sitek, A.; Giannopoulos, K.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Plinabulin after autologous hematopoietic cell transplant to decrease duration of neutropenia and improve quality of life peri-transplant
    Meeting Abstract

    Shah, G.; Shulman, L.; Hanley, D.; Chung, D.; Datta, A.; Dhar, P.; Gupta, G.; Hassoun, H.; Hoover, E.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save